Jefferies Group LLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Put Options

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $11.1 Million - $15 Million	-20,300 Closed	0 $0
Q1 2022 Sep 21, 2023	BUY	$595.12 - $698.43 $6.13 Million - $7.19 Million	10,300 Added 103.0%	20,300 $14.2 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $6.13 Million - $7.19 Million	10,300 Added 103.0%	20,300 $14.2 Million
Q4 2020 Sep 21, 2023	BUY	$478.3 - $607.98 $4.78 Million - $6.08 Million	10,000 New	10,000 $4.83 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $1.87 Million - $2.45 Million	3,800 Added 61.29%	10,000 $6.24 Million
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $2.42 Million - $3.56 Million	-7,200 Reduced 53.73%	6,200 $3.03 Million
Q4 2019 Feb 13, 2020	BUY	$274.13 - $376.51 $2 Million - $2.75 Million	7,300 Added 119.67%	13,400 $5.03 Million
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $1.91 Million - $2.23 Million	-7,000 Reduced 53.44%	6,100 $1.69 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $3.92 Million - $5.43 Million	13,100 New	13,100 $4.1 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $1.88 Million - $2.26 Million	-5,600 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $1.86 Million - $2.17 Million	5,300 Added 1766.67%	5,600 $2.26 Million
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $882,260 - $1.07 Million	-3,100 Reduced 91.18%	300 $103,000
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $315,820 - $393,780	-1,000 Reduced 22.73%	3,400 $1.17 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $1.43 Million - $1.88 Million	4,000 Added 1000.0%	4,400 $1.65 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $172,552 - $201,600	400	400 $179,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account